PITX3
Basic information
Region (hg38): 10:102230189-102241512
Previous symbols: [ "ASMD" ]
Links
Phenotypes
GenCC
Source:
- cataract 11 multiple types (Definitive), mode of inheritance: AD
- anterior segment dysgenesis 1 (Definitive), mode of inheritance: AD
- cataract 9 multiple types (Definitive), mode of inheritance: AD
- anterior segment dysgenesis 1 (Strong), mode of inheritance: AD
- anterior segment dysgenesis 1 (Moderate), mode of inheritance: AD
- cataract-glaucoma syndrome (Supportive), mode of inheritance: AD
- early-onset posterior polar cataract (Supportive), mode of inheritance: AD
- cataract 11 multiple types (Strong), mode of inheritance: AD
- anterior segment dysgenesis 1 (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Cataract 11, multiple types; Cataract 11, syndromic; Anterior segment dysgenesis 1 | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Ophthalmologic | 6801987; 9620774; 10361984; 15286169; 16565358; 17888164; 18989383; 21633712; 22223473 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (2 variants)
- Cataract 11 multiple types (1 variants)
- Cataract 11, posterior polar (1 variants)
- ANTERIOR SEGMENT DYSGENESIS 1, MULTIPLE SUBTYPES (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PITX3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 11 | |||||
missense | 23 | 23 | ||||
nonsense | 3 | |||||
start loss | 0 | |||||
frameshift | 4 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 4 | |||||
Total | 2 | 3 | 28 | 10 | 3 |
Variants in PITX3
This is a list of pathogenic ClinVar variants found in the PITX3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-102230515-C-A | Developmental cataract | Likely pathogenic (May 01, 2021) | ||
10-102230579-C-A | Inborn genetic diseases | Uncertain significance (Jun 18, 2024) | ||
10-102230650-T-C | Uncertain significance (Feb 01, 2021) | |||
10-102230652-C-T | Likely benign (Feb 03, 2022) | |||
10-102230661-G-T | PITX3-related disorder | Likely pathogenic (Jun 11, 2018) | ||
10-102230664-G-A | PITX3-related disorder | Likely benign (Mar 01, 2019) | ||
10-102230683-G-A | Inborn genetic diseases | Uncertain significance (Jun 29, 2023) | ||
10-102230682-C-CGCG | Uncertain significance (Aug 31, 2022) | |||
10-102230685-G-A | PITX3-related disorder | Likely benign (Mar 05, 2024) | ||
10-102230720-C-T | PITX3-related disorder | Uncertain significance (Aug 24, 2023) | ||
10-102230724-C-T | Likely benign (Sep 15, 2022) | |||
10-102230741-C-T | Uncertain significance (Jul 27, 2022) | |||
10-102230746-G-A | Inborn genetic diseases | Uncertain significance (Nov 03, 2022) | ||
10-102230746-G-T | Inborn genetic diseases | Uncertain significance (Oct 05, 2023) | ||
10-102230753-CG-C | Uncertain significance (Aug 09, 2023) | |||
10-102230754-G-A | Likely benign (Dec 30, 2023) | |||
10-102230761-C-G | Uncertain significance (Dec 01, 2023) | |||
10-102230762-C-T | Uncertain significance (Jul 29, 2023) | |||
10-102230765-C-CGGCCCTGCAGGGTCTGG | Pathogenic (Jul 12, 2021) | |||
10-102230766-GCCCAGGCCCTGCAGGGC-G | Cataract 11 multiple types | Likely pathogenic (Jan 19, 2024) | ||
10-102230766-G-GCCCAGGCCCTGCAGGGC | Cataract 11, posterior polar • ANTERIOR SEGMENT DYSGENESIS 1, MULTIPLE SUBTYPES • Cataract 11 multiple types • PITX3-related disorder | Pathogenic (Jun 15, 2023) | ||
10-102230772-GC-G | Cataract 11, posterior polar, with microphthalmia and neurodevelopmental abnormalities • Cataract 11, posterior polar | Pathogenic (Apr 01, 2006) | ||
10-102230777-G-A | Likely pathogenic (Feb 10, 2016) | |||
10-102230785-C-CCA | Pathogenic (Jun 14, 2021) | |||
10-102230793-T-G | PITX3-related disorder | Likely benign (Jun 17, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PITX3 | protein_coding | protein_coding | ENST00000370002 | 3 | 11289 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.813 | 0.186 | 110771 | 0 | 1 | 110772 | 0.00000451 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.50 | 115 | 170 | 0.677 | 0.00000791 | 1874 |
Missense in Polyphen | 14 | 38.755 | 0.36124 | 408 | ||
Synonymous | 0.542 | 75 | 81.2 | 0.923 | 0.00000395 | 666 |
Loss of Function | 2.62 | 1 | 9.90 | 0.101 | 4.24e-7 | 108 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000315 | 0.0000315 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Transcriptional regulator which is important for the differentiation and maintenance of meso-diencephalic dopaminergic (mdDA) neurons during development. In addition to its importance during development, it also has roles in the long-term survival and maintenance of the mdDA neurons. Activates NR4A2/NURR1- mediated transcription of genes such as SLC6A3, SLC18A2, TH and DRD2 which are essential for development of mdDA neurons. Acts by decreasing the interaction of NR4A2/NURR1 with the corepressor NCOR2/SMRT which acts through histone deacetylases (HDACs) to keep promoters of NR4A2/NURR1 target genes in a repressed deacetylated state. Essential for the normal lens development and differentiation. Plays a critical role in the maintenance of mitotic activity of lens epithelial cells, fiber cell differentiation and in the control of the temporal and spatial activation of fiber cell-specific crystallins. Positively regulates FOXE3 expression and negatively regulates PROX1 in the anterior lens epithelium, preventing activation of CDKN1B/P27Kip1 and CDKN1C/P57Kip2 and thus maintains lens epithelial cells in cell cycle (By similarity). {ECO:0000250}.;
- Disease
- DISEASE: Cataract 11, multiple types (CTRCT11) [MIM:610623]: An opacification of the crystalline lens of the eye that frequently results in visual impairment or blindness. Opacities vary in morphology, are often confined to a portion of the lens, and may be static or progressive. CTRCT11 includes posterior polar cataract, among others. Posterior polar cataract is a subcapsular opacity, usually disk-shaped, located at the back of the lens. Some CTRCT11 patients can present a severe phenotype including microphthalmia and neurological dysfunction. {ECO:0000269|PubMed:15286169, ECO:0000269|PubMed:9620774}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Dopaminergic Neurogenesis
(Consensus)
Recessive Scores
- pRec
- 0.193
Haploinsufficiency Scores
- pHI
- 0.445
- hipred
- Y
- hipred_score
- 0.736
- ghis
- 0.665
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.647
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pitx3
- Phenotype
- immune system phenotype; skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; pigmentation phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; liver/biliary system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype;
Zebrafish Information Network
- Gene name
- pitx3
- Affected structure
- mandibular arch skeleton
- Phenotype tag
- abnormal
- Phenotype quality
- morphology
Gene ontology
- Biological process
- lens development in camera-type eye;lens morphogenesis in camera-type eye;regulation of transcription, DNA-templated;aging;locomotory behavior;anatomical structure morphogenesis;animal organ morphogenesis;negative regulation of gliogenesis;midbrain development;response to immobilization stress;response to cocaine;response to morphine;positive regulation of neuron apoptotic process;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;neuron development;lens fiber cell differentiation;dopaminergic neuron differentiation;response to methamphetamine hydrochloride;positive regulation of cell proliferation in midbrain;cellular response to glial cell derived neurotrophic factor
- Cellular component
- nucleus;neuronal cell body
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;RNA polymerase II transcription factor binding;sequence-specific DNA binding